Drug Discovery and Development Analysis & Statistics, January 2013 (p40)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1171-1210 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

Toll-Like Receptor 5 (TLR-5) Agonists -Pipeline Insights, 2014

Toll-Like Receptor 5 (TLR-5) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor 5 (TLR-5) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor 7 (TLR-7) Agonists -Pipeline Insights, 2014

Toll-Like Receptor 7 (TLR-7) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor 7 (TLR-7) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor 8 (TLR-8) Agonists -Pipeline Insights, 2014

Toll-Like Receptor 8 (TLR-8) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor 8 (TLR-8) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor 9 (TLR-9) Antagonists -Pipeline Insights, 2014

Toll-Like Receptor 9 (TLR-9) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor 9 (TLR-9) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor Agonists -Pipeline Insights, 2014

Toll-Like Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor Antagonists -Pipeline Insights, 2014

Toll-Like Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Toll-Like Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Topoisomerase Inhibitors -Pipeline Insights, 2014

Topoisomerase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Topoisomerase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights, 2014

TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists -Pipeline Insights, 2014

TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
TRAIL Receptor Agonists -Pipeline Insights, 2014

TRAIL Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRAIL Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2014

Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transcription Factor Activator Protein-1 (AP-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2014

Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transforming Growth Factor Alpha (TGFa) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2014

Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transforming Growth Factor Beta (TGFb) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Transglutaminase 2 Inhibitors -Pipeline Insights, 2014

Transglutaminase 2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transglutaminase 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014

Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs ...

  • Industries : Drug Discovery and Development
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014

Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs ...

  • Industries : Drug Discovery and Development
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014

TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline ...

  • Industries : Drug Discovery and Development
Trypsin Inhibitors -Pipeline Insights, 2014

Trypsin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Trypsin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014

Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014

Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ubiquitin Specific Proteases (USP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“UMP-CMP Kinase (UMP-CMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor A (VEGF-A) Activator-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Agonists -Pipeline Insights, 2014

Vasopressin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Antagonists -Pipeline Insights, 2014

Vasopressin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V1a Receptor (V1aR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development

82 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.